(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

REVIR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

REVIR

ST13

US500000097196705

Class

42

Filing

97196705

Registration

6963609

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

01/24/2023

Trademark type

Word

Nice classes

42

Filing date

12/30/2021

Registration date

01/24/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/24/2023

Last transaction

01/24/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

05/10/2021

First use in commerce

05/10/2021

Drawing code

4

Owner type

03

Owner location

Foster City, CA, US

Examiner

LOVELACE, JAMES

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Revir Therapeutics, Inc.

Representatives

Enshan Hong MAGSTONE LAW, LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Scientific research in the field of genetics and genetic engineering; Scientific research consulting in the field of molecular biologybiotechnologypharmaceuticsimmunology and oncologybacteriologymedical diagnostics and therapy using molecular biologicalgenetic engineering and biotechnological methodsscientific research related to screening for pharmaceutically active compounds; Medical and scientific research in the field of molecular biologybiotechnologypharmaceuticsimmunology and oncologybacteriologymedical diagnostics and therapy using molecular biologicalgenetic engineering and biotechnological methodsscientific research related to screening for pharmaceutically active compounds; Scientific research and development; Scientific research and development of diagnostic methods and test processes; Scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; Scientific consultancy services in the field of research and development of therapies and medical preparations; Provision of scientific expertise in the nature of scientific study and research in the field of medicine; Scientific research and development for medical and veterinary purposes; Medical and scientific research in the field of treatment of proliferating diseasescancersinfectious diseasesautoimmune diseasesneurodegenerative diseasemetabolic diseases; Providing medical and scientific research informationconsultancyadvisory services in the fields of treatment of proliferating diseasescancersinfectious diseasesautoimmune diseasesneurodegenerative disease; Compiling data for medical and scientific researchclinical trialsdrug admission

Publications

History of USPTO decisions and trademark events.

17 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/24/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

01/24/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/08/2022

PUBO

PUBLISHED FOR OPPOSITION

11/08/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/19/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/05/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

10/05/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/05/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

10/05/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/05/2022

DOCK

ASSIGNED TO EXAMINER

10/04/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/01/2022

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

09/01/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/01/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/01/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/05/2022

NWAP

NEW APPLICATION ENTERED

01/03/2022

Continuous trademark protection

Get notified about every new filing that threatens REVIR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.